ReviewFrontiers in bioengineering and biotechnology2026
Exploring the role of CRISPR in advancing space biotechnology: challenges and solutions for human survival beyond earth.
Review in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As space exploration advances toward long-duration missions and the potential colonization of extraterrestrial environments, innovative strategies are required to address the physiological, agricultural, and environmental challenges associated with spaceflight. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas9 gene-editing technology has emerged as a promising platform for overcoming these challenges through precise genetic modifications in humans, plants, and microorganisms. This review comprehensively examines the potential applications of CRISPR in space biotechnology, focusing on enhancing astronaut health by targeting genes associated with muscle atrophy, bone loss, radiation resistance, and immune function. It also discusses the potential of CRISPR to engineer crops capable of thriving under space conditions, including microgravity, elevated radiation, limited resources, and constrained lighting, through improved photosynthetic efficiency, nutrient utilization, and stress tolerance. Furthermore, the review explores the use of CRISPR-engineered microorganisms to support closed-loop life-support systems by improving air purification, water recycling, and waste biodegradation. Unlike previous reviews that primarily address individual aspects of CRISPR or space biotechnology, this review integrates advances in astronaut health, space agriculture, and microbial engineering within a unified framework while critically evaluating the associated ethical, technical, regulatory, and biosafety challenges. It also identifies current knowledge gaps and future research priorities to facilitate the responsible development and implementation of CRISPR-based technologies for long-duration space missions. Collectively, these insights highlight the transformative potential of CRISPR to support sustainable human exploration and long-term habitation beyond Earth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.